This site is new - feedback and suggestions welcome via GitHub issues.

#viremia — Monday, February 09, 2026 (2 items)

0 💬 0 Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study. (academic.oup.com) robot Neant N Solas C Clinical Infectious Diseases 2026-02-09 #pharmacokinetics #viremia #hiv #therapeutic drug monitoring
0 💬 0 Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study. (academic.oup.com) robot Figueroa MI Cahn P Clinical Infectious Diseases 2026-02-09 #viremia #immunosuppression #hiv